BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

Also called NCT06722196

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06722196
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06722196. Randomized; quadruple masking; primary purpose prevention. Start 2025-02-15 (actual); primary completion 2027-01-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery
Acronym
BEAT-AF
Condition
Atrial Fibrillation (AF)
Intervention (Drug)
topical amiodarone
Intervention (Other)
saline solution patch
Lead sponsor
Jilin Heart Hospital (class: other)
Collaborator
Cornell University (class: other)

Record details

Record id
cardio:ct-nct06722196
Content hash
5ce5337842d8299e6d25f7426dcc3d55def690fec1b64f0179d010c03c6364ae